Podcast – Persistent seizures: How to use the ketogenic diet for super-refractory status epilepticus

A recent paper in Neurology Clinical Practice offers practical considerations for using the ketogenic diet in patients with seizures that last more than 24 hours, a condition known as super-refractory status epilepticus. ILAE spoke with two of the authors – dietitian Neha Kaul and epileptologist Joshua Laing.

Podcast – Dieta cetogénica y estatus epiléptico súper refractario

Un artículo reciente en “Neurology Clinical Practice” ofrece consideraciones prácticas para el empleo de la dieta cetogénica en pacientes con estatus epiléptico superrefractario. La ILAE habló con dos de los autores del artículo. (Podcast en ingles; transcripcion en español.)

Can community-based interventions help to close the epilepsy treatment gap?

More than 50 million people have epilepsy; about 80% live in lower- or middle-income countries, where diagnosis and treatment can be difficult or impossible. The percentage of people with epilepsy that is not receiving treatment is known as the treatment gap; in some countries, this gap exceeds 90%.

Suspended studies and virtual lab meetings: How the COVID-19 pandemic is affecting epilepsy researchers

How was epilepsy research forced to morph during the first few months of the COVID-19 pandemic? Researchers from 11 countries shared their experiences and thoughts on the future of laboratory research, clinical trials, and in-person conferences.

When seizures don’t stop: What’s the latest in treating status epilepticus?

When seizures last longer than about 5 minutes–a condition called status epilepticus–emergency treatment is required. About two-thirds of people respond to initial treatment with benzodiazepines, but the others need a second drug. Which drug to choose is a matter of some debate.

Epilepsy is a threat to public health, says international report

Worldwide, more than 50 million people are living with epilepsy. As many as 37 million are not receiving treatment, though it can cost as little as US$5 a year and eliminates seizures about two-thirds of the time. These findings and many others are published in “Epilepsy: A public health imperative”, a report produced by ILAE, the World Health Organization and the International Bureau for Epilepsy.

Epilepsy is a threat to public health, says international report

Worldwide, more than 50 million people are living with epilepsy. As many as 37 million are not receiving treatment, though it can cost as little as US$5 a year and eliminates seizures about two-thirds of the time. These findings and many others are published in “Epilepsy: A public health imperative”, a report produced by ILAE, the World Health Organization and the International Bureau for Epilepsy.